Advertisement
Screener

AIM IMMUNOTECH INC. (AIM) Operating Lease Right-of-Use Assets

2.8 / 5 stars · 68/120 Roast Me

AIM IMMUNOTECH INC. Operating Lease Right-of-Use Assets

AIM IMMUNOTECH INC. (AIM) had Operating Lease Right-of-Use Assets of $260.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Balance Sheet › Assets › Assets, Noncurrent

us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-07

  • 2026-06-30: Operating Lease, Right-of-Use Asset $260.00K.
  • 2026-03-31: Operating Lease, Right-of-Use Asset $320.00K.
  • 2025-12-31: Operating Lease, Right-of-Use Asset $378.00K.
  • 2025-09-30: Operating Lease, Right-of-Use Asset $436.00K.
Period endOperating Lease, Right-of-Use Asset
2026-06-30$260.00K
10-Q · filed 2026-08-07
2026-03-31$320.00K
10-Q · filed 2026-05-15
2025-12-31$378.00K
10-Q · filed 2026-08-07
2025-09-30$436.00K
10-Q · filed 2025-11-17
2025-06-30$496.00K
10-Q · filed 2025-08-14
2025-03-31$554.00K
10-Q · filed 2025-05-15
2024-12-31$618.00K
10-K · filed 2026-03-27
2024-09-30$653.00K
10-Q · filed 2024-11-14
2024-06-30$700.00K
10-Q · filed 2024-08-14
2024-03-31$763.00K
10-Q · filed 2024-05-15
2023-12-31$697.00K
10-K · filed 2025-03-27
2023-09-30$727.00K
10-Q · filed 2023-11-14
2023-06-30$781.00K
10-Q · filed 2023-08-14
2023-03-31$792.00K
10-Q · filed 2023-05-15
2022-12-31$829.00K
10-K · filed 2024-04-01
2022-09-30$866.00K
10-Q · filed 2022-11-14
2022-06-30$889.00K
10-Q · filed 2022-08-15
2022-03-31$144.00K
10-Q · filed 2022-05-13
2021-12-31$149.00K
10-K · filed 2023-03-31
2021-09-30$144.00K
10-Q · filed 2021-11-15
2021-06-30$157.00K
10-Q · filed 2021-08-16
2021-03-31$168.00K
10-Q · filed 2021-05-17
2020-12-31$179.00K
10-K · filed 2022-03-31
2020-09-30$188.00K
10-Q · filed 2020-11-12
2020-06-30$130.00K
10-Q · filed 2020-08-14
2020-03-31$141.00K
10-Q · filed 2020-05-14
2019-12-31$152.00K
10-K · filed 2021-03-31
2019-09-30$162.00K
10-Q · filed 2019-11-14
2019-06-30$173.00K
10-Q · filed 2019-08-14
2019-03-31$137.00K
10-Q · filed 2019-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Silexion Therapeutics Corp (SLXN)$0.001B